Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000597489 | SCV000707332 | likely pathogenic | not provided | 2017-04-18 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001042605 | SCV001206299 | pathogenic | Glycogen storage disease IXa1 | 2022-06-09 | criteria provided, single submitter | clinical testing | This variant has been observed in individual(s) with glycogen storage disease type IX (PMID: 17689125, 26157701, 27103379, 34277355). In at least one individual the variant was observed to be de novo. This variant, c.3210_3212del, results in the deletion of 1 amino acid(s) of the PHKA2 protein (p.Arg1072del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant is also known as c.3208_3210delGAG. ClinVar contains an entry for this variant (Variation ID: 501100). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. For these reasons, this variant has been classified as Pathogenic. |
Molecular Genetics Lab, |
RCV001042605 | SCV004697668 | pathogenic | Glycogen storage disease IXa1 | criteria provided, single submitter | clinical testing | ||
Genomics And Bioinformatics Analysis Resource, |
RCV001042605 | SCV004024097 | likely pathogenic | Glycogen storage disease IXa1 | no assertion criteria provided | research |